Acute Coronary Syndromes
News
ACS stent thrombosis indication for rivaroxaban not approved, company says
News
Postop troponin elevation, MI impact 5-year survival
Major finding: Postoperative ischemia in the form of a troponin elevation increased the hazard of death at 5 years by 45% (HR, 1.45; P =.01) while...
News
Hospital revenue generated by cardiologists continues to drop
Video
FDA panels revisit rosiglitazone's cardiovascular safety
News
Cholinesterase inhibitors may protect the heart
Major finding: Alzheimer’s patients who use cholinesterase inhibitors, compared with those who do not, have a 38% reduction in heart attack risk...
News
Physician passengers handle half of in-flight emergencies
News
FDA panel starts review of rosiglitazone CV data
News
Swedish NSTEMI registry suggests comparability of heparin, bivalirudin
Major finding:NSTE-ACS patients treated with heparin or bivalirudin had similar 30-day mortality rates following PCI. Data source: An analysis of...
News
EU approves rivaroxaban for secondary prevention
News
Treadmill 1-km walk test predicts prognosis in cardiac disease
Major finding: During a median follow-up of 8 years, 11% of the patients died.
News
Telemonitored cardiac rehabilitation boosts compliance
Major finding: Telemedicine achieved 95% compliance with at-home cardiac rehabilitation among elderly cardiac patients.Data source: A review of...